Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer

OBJECTIVE: The aim of the present subgroup analysis of the FRESCO trial is to determine the efficacy and hepatotoxicity of fruquintinib in Chinese patients with metastatic CRC with liver metastasis (CRLM) who were receiving third-line or posterior-line therapy. METHODS: Overall survival (OS) and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Shukui, Xu, Rui-Hua, Shen, Lin, Xu, Jianming, Bai, Yuxian, Yang, Lei, Deng, Yanhong, Chen, Zhen-dong, Zhong, Haijun, Pan, Hongming, Guo, Weijian, Shu, Yongqian, Yuan, Ying, Zhou, Jianfeng, Xu, Nong, Liu, Tianshu, Ma, Dong, Wu, Changping, Cheng, Ying, Chen, Donghui, Li, Wei, Sun, Sanyuan, Yu, Zhuang, Cao, Peiguo, Chen, Haihui, Wang, Jiejun, Wang, Shubin, Wang, Hongbing, Wang, Ning, Zhang, Bin, Zhang, Qiang, Su, Weiguo, Guo, Xiaojun, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364970/
https://www.ncbi.nlm.nih.gov/pubmed/34408440
http://dx.doi.org/10.2147/OTT.S307273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364970/
https://www.ncbi.nlm.nih.gov/pubmed/34408440
http://dx.doi.org/10.2147/OTT.S307273

Ejemplares similares